image
Seres Therapeutics, Inc. MCRB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.5497
-7.16 %
$ 93.6 M
Market Cap
-0.46
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 1672.24% 55.20% 56.19%
Annual Report FY 10-K 2022-12-31 -95.08% -312.75% -282.20%
Annual Report FY 10-K 2021-12-31 336.33% 28.87% 26.82%
Annual Report FY 10-K 2020-12-31 -3.74% -34.57% -22.61%
Annual Report FY 10-K 2019-12-31 22.07% 35.07% 28.33%
Annual Report FY 10-K 2018-12-31 -11.94% -10.70% -9.73%
Annual Report FY 10-K 2017-12-31 47.48% 2.40% 1.56%
Annual Report FY 10-K 2016-12-31 0.00% -67.18% -69.24%
Annual Report FY 10-K 2015-12-31 0.00% -227.85% -263.72%
Annual Report FY 10-K 2014-12-31 0.00% -173.83% -149.21%
Annual Report FY 10-K 2013-12-31 0.00% -95.20% -99.54%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 285.51% 38.48%
Quarterly Report Q2 8-K 2024-06-30 0.00% -70.61% -63.29%
Quarterly Report Q1 8-K 2024-03-31 100.00% 44.09% 47.33%
Quarterly Report Q4 8-K 2023-12-31 -93.44% 40.47% 35.56%
Quarterly Report Q3 8-K 2023-09-30 -91.00% 20.25% 19.78%
Quarterly Report Q2 8-K 2023-06-30 10300.74% 171.91% 178.21%
Quarterly Report Q1 8-K 2023-03-31 -34.96% -24.84% -26.58%
Quarterly Report Q4 8-K 2022-12-31 -86.50% -38.57% -38.18%
Quarterly Report Q3 8-K 2022-09-30 -97.28% -87.96% -86.40%
Quarterly Report Q2 8-K 2022-06-30 -76.90% -33.94% -31.54%
Quarterly Report Q1 8-K 2022-03-31 -73.89% -62.12% -57.82%
Quarterly Report Q4 8-K 2021-12-31 -58.89% -173.95% -176.19%
Quarterly Report Q3 8-K 2021-09-30 8843.19% 325.29% 328.06%
Quarterly Report Q2 8-K 2021-06-30 -12.94% -133.32% -134.32%
Quarterly Report Q1 8-K 2021-03-31 -30.17% -78.39% -79.39%
Quarterly Report Q4 8-K 2020-12-31 130.44% 2.80% 6.74%
Quarterly Report Q3 8-K 2020-09-30 -79.85% -84.53% -74.56%
Quarterly Report Q2 8-K 2020-06-30 -51.76% -92.53% -87.66%
Quarterly Report Q1 8-K 2020-03-31 11.86% 18.30% 19.80%
Quarterly Report Q4 8-K 2019-12-31 -28.29% 11.79% 11.44%
Quarterly Report Q3 8-K 2019-09-30 -22.35% 25.24% 22.64%
Quarterly Report Q2 8-K 2019-06-30 171.70% 61.28% 61.09%
Quarterly Report Q1 8-K 2019-03-31 84.36% 12.84% 13.14%
Quarterly Report Q4 8-K 2018-12-31 247.81% 26.48% 27.22%
Quarterly Report Q3 8-K 2018-09-30 -60.66% -216.50% -203.68%
Quarterly Report Q2 8-K 2018-06-30 53.02% 0.82% 0.99%
Quarterly Report Q1 8-K 2018-03-31 31.71% -9.60% -9.18%
Quarterly Report Q4 8-K 2017-12-31 0.66% -14.55% -15.98%
Quarterly Report Q3 8-K 2017-09-30 76.83% 62.89% 61.70%
Quarterly Report Q2 8-K 2017-06-30 0.33% -0.38% -0.98%
Quarterly Report Q1 8-K 2017-03-31 11.25% -29.28% -30.00%
Quarterly Report Q4 8-K 2016-12-31 0.00% -28.74% -29.74%
Quarterly Report Q3 8-K 2016-09-30 0.00% -27.82% -31.14%
Quarterly Report Q2 8-K 2016-06-30 0.00% -122.33% -128.04%
Quarterly Report Q1 8-K 2016-03-31 0.00% -147.20% -143.86%
Quarterly Report Q4 8-K 2015-12-31 0.00% -139.97% -174.34%
Quarterly Report Q3 8-K 2015-09-30 0.00% -251.36% -306.85%
Quarterly Report Q2 8-K 2015-06-30 0.00% -369.00% -371.35%
Quarterly Report Q1 8-K 2015-03-31 0.00% -371.94% -388.46%
Quarterly Report Q4 8-K 2014-12-31 0.00% -277.05% -278.64%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%